Product Information
QC ALLERGY MULTI-SYMPTOM CPLT is a generic product labeled by Chain Drug Marketing Association, priced at $0.0863 per EA under NDC 83324008624. Its NADAC has been published 95 times since Dec 11, 2024.
QC ALLERGY MULTI-SYMPTOM CPLT
ACETAMINOPHEN, CHLORPHENIRAMINE MALEATE, and PHENYLEPHRINE HYDROCHLORIDEStrength
325; 2; 5 mg/1; mg/1; mg/1
Manufacturer
Chain Drug Marketing AssociationNDC
83324008624
Classification
Generic
Dosage Form
TABLET, COATED
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
ACETAMINOPHEN; CHLORPHENIRAMINE MALEATE; PHENYLEPHRINE HYDROCHLORIDEApproval Type
OTC MONOGRAPH DRUG
FDA Application
M012On Market Since
8/12/2024
Pharmacological Classes
Price Statistics
The NADAC for QC ALLERGY MULTI-SYMPTOM CPLT has been published 95 times since Dec 11, 2024, and over the history we have for it it has risen 6.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0863 per EA |
|---|---|
| All-time high | $0.0887 (Aug 12, 2026) |
| All-time low | $0.0786 (Dec 18, 2024) |
| 52-week high | $0.0887 |
| 52-week low | $0.0828 |
| Median price | $0.0839 |
| Average price | $0.0842 |
| Largest weekly change | -4.2% (Jul 23, 2025) |
| Weeks tracked | 95 |
| Tracking since | Dec 11, 2024 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Chain Drug Marketing Association manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
ACETAMINOPHEN, CHLORPHENIRAMINE MALEATE, and PHENYLEPHRINE HYDROCHLORIDE market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Histamine-1 Receptor Antagonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of QC ALLERGY MULTI-SYMPTOM CPLT?
The current National Average Drug Acquisition Cost (NADAC) for QC ALLERGY MULTI-SYMPTOM CPLT, manufactured by Chain Drug Marketing Association, is $0.0863 per EA (NDC 83324008624), effective Sep 30, 2026.
How has the price of QC ALLERGY MULTI-SYMPTOM CPLT changed over time?
Over the history we have for it, the NADAC for QC ALLERGY MULTI-SYMPTOM CPLT has risen 6.1%. It has been tracked across 95 weekly CMS publications since Dec 11, 2024.
What are the highest and lowest recorded NADAC prices for QC ALLERGY MULTI-SYMPTOM CPLT?
Since Dec 11, 2024, the NADAC for QC ALLERGY MULTI-SYMPTOM CPLT has ranged from a low of $0.0786 (Dec 18, 2024) to a high of $0.0887 (Aug 12, 2026), with a median of $0.0839 per EA.
Are there cheaper alternatives to QC ALLERGY MULTI-SYMPTOM CPLT?
2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as QC ALLERGY MULTI-SYMPTOM CPLT in a comparable dosage form, but none are currently priced below it.
Who manufactures QC ALLERGY MULTI-SYMPTOM CPLT?
QC ALLERGY MULTI-SYMPTOM CPLT (NDC 83324008624) is labeled by Chain Drug Marketing Association, and CMS classifies it as a generic product.